Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Study Finds Common Fatty Acid May Increase Pain, Temperature Sensitivity in Psoriasis By: Investor Brand Network February 15, 2023 at 12:25 PM EST Psoriasis is a skin condition that causes flaky skin patches which form scales. The condition’s symptoms include dry skin lesions called plaques, which can appear anywhere on one’s body, including the knees, elbows, lower back and scalp. While the condition’s primary cause remains unknown, researchers believe that it may be caused by cells that fight infection mistakenly attacking healthy skin cells. New research carried out by North Carolina State University scientists has found that linoleic acid may increase sensitivity to pain and… Read More>> NOTE TO INVESTORS: The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV About BioMedWire BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge. To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only) For more information, please visit https://www.biomedwire.com Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer BioMedWire (BMW)San Francisco, Californiawww.biomedwire.com415.949.5050 OfficeEditor@BioMedWire.com BioMedWire is part of the InvestorBrandNetwork. Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Study Finds Common Fatty Acid May Increase Pain, Temperature Sensitivity in Psoriasis By: Investor Brand Network February 15, 2023 at 12:25 PM EST Psoriasis is a skin condition that causes flaky skin patches which form scales. The condition’s symptoms include dry skin lesions called plaques, which can appear anywhere on one’s body, including the knees, elbows, lower back and scalp. While the condition’s primary cause remains unknown, researchers believe that it may be caused by cells that fight infection mistakenly attacking healthy skin cells. New research carried out by North Carolina State University scientists has found that linoleic acid may increase sensitivity to pain and… Read More>> NOTE TO INVESTORS: The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV About BioMedWire BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge. To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only) For more information, please visit https://www.biomedwire.com Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer BioMedWire (BMW)San Francisco, Californiawww.biomedwire.com415.949.5050 OfficeEditor@BioMedWire.com BioMedWire is part of the InvestorBrandNetwork.
Psoriasis is a skin condition that causes flaky skin patches which form scales. The condition’s symptoms include dry skin lesions called plaques, which can appear anywhere on one’s body, including the knees, elbows, lower back and scalp. While the condition’s primary cause remains unknown, researchers believe that it may be caused by cells that fight infection mistakenly attacking healthy skin cells. New research carried out by North Carolina State University scientists has found that linoleic acid may increase sensitivity to pain and… Read More>> NOTE TO INVESTORS: The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV About BioMedWire BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge. To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only) For more information, please visit https://www.biomedwire.com Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer BioMedWire (BMW)San Francisco, Californiawww.biomedwire.com415.949.5050 OfficeEditor@BioMedWire.com BioMedWire is part of the InvestorBrandNetwork.